JPMorgan Chase & Co. Purchases 173,710 Shares of Nu Skin Enterprises, Inc. (NYSE:NUS)

JPMorgan Chase & Co. lifted its position in shares of Nu Skin Enterprises, Inc. (NYSE:NUS) by 74.9% during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 405,667 shares of the company’s stock after buying an additional 173,710 shares during the quarter. JPMorgan Chase & Co.’s holdings in Nu Skin Enterprises were worth $2,795,000 at the end of the most recent quarter.

Several other hedge funds also recently bought and sold shares of NUS. Bank of New York Mellon Corp lifted its holdings in shares of Nu Skin Enterprises by 18.5% in the fourth quarter. Bank of New York Mellon Corp now owns 613,330 shares of the company’s stock worth $4,226,000 after buying an additional 95,938 shares in the last quarter. American Century Companies Inc. increased its holdings in Nu Skin Enterprises by 12.0% in the 4th quarter. American Century Companies Inc. now owns 824,739 shares of the company’s stock valued at $5,682,000 after acquiring an additional 88,181 shares during the last quarter. AlphaQuest LLC lifted its stake in Nu Skin Enterprises by 197.8% in the 4th quarter. AlphaQuest LLC now owns 108,204 shares of the company’s stock worth $746,000 after purchasing an additional 71,864 shares in the last quarter. Barclays PLC lifted its stake in Nu Skin Enterprises by 363.8% in the 3rd quarter. Barclays PLC now owns 85,437 shares of the company’s stock worth $629,000 after purchasing an additional 67,016 shares in the last quarter. Finally, Rhumbline Advisers boosted its holdings in shares of Nu Skin Enterprises by 70.9% during the 4th quarter. Rhumbline Advisers now owns 138,477 shares of the company’s stock valued at $954,000 after purchasing an additional 57,443 shares during the last quarter. Institutional investors own 82.84% of the company’s stock.

Analyst Ratings Changes

Separately, StockNews.com downgraded Nu Skin Enterprises from a “buy” rating to a “hold” rating in a research report on Tuesday, April 8th.

Nu Skin Enterprises Trading Down 0.9 %

NUS stock opened at $5.52 on Wednesday. The firm has a fifty day moving average price of $7.17 and a 200 day moving average price of $6.96. Nu Skin Enterprises, Inc. has a fifty-two week low of $5.32 and a fifty-two week high of $14.00. The firm has a market cap of $274.47 million, a PE ratio of -1.87 and a beta of 1.10. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.17 and a current ratio of 1.82.

Nu Skin Enterprises (NYSE:NUS) last issued its quarterly earnings data on Thursday, February 13th. The company reported $0.38 EPS for the quarter, topping analysts’ consensus estimates of $0.24 by $0.14. Nu Skin Enterprises had a negative net margin of 8.46% and a positive return on equity of 5.86%. The business had revenue of $445.55 million during the quarter, compared to analysts’ expectations of $441.10 million. Sell-side analysts anticipate that Nu Skin Enterprises, Inc. will post 1.05 earnings per share for the current fiscal year.

Nu Skin Enterprises Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, March 5th. Shareholders of record on Monday, February 24th were paid a dividend of $0.06 per share. The ex-dividend date of this dividend was Monday, February 24th. This represents a $0.24 annualized dividend and a yield of 4.35%. Nu Skin Enterprises’s payout ratio is currently -8.14%.

Nu Skin Enterprises Profile

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.